Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort

View ORCID ProfileRilwan Azeez, View ORCID ProfileLarisa Lotoski, Geoffrey L. Winsor, Corey R. Arnold, Yannick Galipeau, Martin Pelchat, Stephanie Goguen, View ORCID ProfileElinor Simons, Theo J. Moraes, View ORCID ProfilePiush J. Mandhane, Stuart E. Turvey, Shelly Bolotin, David M. Patrick, Jared Bullard, Lisa M. Lix, Natasha Doucas, Natalie Rodriguez, Fiona S.L. Brinkman, Padmaja Subbarao, Marc-André Langlois, View ORCID ProfileMeghan B. Azad
doi: https://doi.org/10.1101/2023.09.06.23294696
Rilwan Azeez
1Department of Immunology, University of Manitoba, Winnipeg, MB, Canada
3Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rilwan Azeez
Larisa Lotoski
2Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
3Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Larisa Lotoski
Geoffrey L. Winsor
4Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corey R. Arnold
5Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yannick Galipeau
5Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Pelchat
5Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Goguen
2Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
3Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elinor Simons
2Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
3Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elinor Simons
Theo J. Moraes
6Division of Respiratory Medicine, Department of Pediatrics and Program in Translational
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piush J. Mandhane
7Medicine, SickKids Research Institute, The Hospital for Sick Children, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Piush J. Mandhane
Stuart E. Turvey
8Department of Pediatrics, University of Alberta, Edmonton, AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelly Bolotin
9Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Patrick
10Centre for Vaccine Preventable Diseases, University of Toronto: Dalla Lana School of Public Health, University of Toronto; Department of Laboratory Medicine and Pathobiology, University of Toronto; Public Health Ontario
11School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jared Bullard
2Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
12British Columbia Centre for Disease Control, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa M. Lix
13Cadham Provincial Laboratory, Manitoba Health, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natasha Doucas
14Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Rodriguez
2Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
3Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona S.L. Brinkman
4Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Padmaja Subbarao
6Division of Respiratory Medicine, Department of Pediatrics and Program in Translational
15CHILD Cohort Study National Parent Engagement Committee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc-André Langlois
5Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghan B. Azad
2Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
3Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Meghan B. Azad
  • For correspondence: meghan.azad{at}umanitoba.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Vaccination helps prevent SARS-CoV-2 infection and severe COVID-19. However, vaccine-induced humoral immune responses vary among individuals and wane over time. We aimed to describe the SARS-CoV-2 anti-spike IgG antibody response to vaccination and identify health and demographic factors associated with this response among children and adults.

Methods We studied a subset of double-vaccinated children (n= 151; mean age: 12 ±1.5 years, 46% female) and adults (n= 995; 44 ±6.0 years, 60% female) from the Canadian CHILD Cohort. Dried blood spots were collected over two time periods (March 2021 to September 2021; October 2021 to January 2022). Antibody levels were quantified using automated chemiluminescent ELISAs. Demographic, vaccination, and health data were collected via online questionnaires. Associations were determined using multivariable regression.

Results Our cohort had SARS-CoV-2 anti-spike seropositivity rate of 97% following two COVID-19 vaccine doses. In both children and adults, the highest antibody levels were observed around three months post-vaccination and did not differ by biological sex. Higher antibody levels were associated with: prior SARS-CoV-2 infection (β=0.15 scaled luminescence units, 95%CI, 0.06-0.24), age <18 years (β=0.15, 95%CI 0.05-0.26) and receiving the Moderna mRNA (β=0.23, 95%CI 0.11-0.34) or Pfizer-BioNTech mRNA vaccines (β= 0.10, 95%CI, 0.02-0.18) vs. a combination of mRNA and Oxford-AstraZeneca viral vector vaccines. There were no differences in antibody levels when comparing a 3-8 vs. 9-16-week interval between vaccine doses.

Interpretation We identified key factors associated with post-vaccination antibody responses in children and adults, which could help improve future vaccine development and deployment among different population subgroups.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by funding from the Canadian Institutes of Health Research and the Canadian COVID-19 Immunity Task Force (VR5-172658) and Research Manitoba (4494). Core funding for the CHILD Cohort Study was provided by the Canadian Institutes of Health Research [CIHR; AEC-85761, PJT-148484, FDN-159935, and EC1-144621], the Allergy, Genes and Environment Network of Centres of Excellence (AllerGen NCE) (12CHILD), BC Children Hospital Foundation, Don & Debbie Morrison, and Genome Canada/Genome BC (274CHI). This research was supported, in part, by the Canada Research Chairs program: MBA holds a Tier 2 Canada Research Chair in the Developmental Origins of Health and Disease; SET holds a Tier 1 Canada Research Chair in Pediatric Precision Health; PS holds Tier 1 Canada Research Chair in Pediatric Asthma & Lung Health EC is supported by a Social Science and Humanities Research Council Postdoctoral Fellowship. FSLB is an SFU Distinguished Professor. YG is supported by a Frederick Banting and Charles Best CGS-D from the Canadian Institutes of Health Research (476885). Production of COVID-19 reagents was financially supported by NRC's Pandemic Response Challenge Program. The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Production of COVID-19 reagents was financially supported by the NRC Pandemic Response Challenge Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Research ethics boards at the University of British Columbia (H20-02324), University of Alberta (Pro00102524), University of Manitoba (HS24250), The Hospital for Sick Children (1000071220) and McMaster University (1108).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

https://childstudy.ca/for-researchers/study-data/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 08, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
Rilwan Azeez, Larisa Lotoski, Geoffrey L. Winsor, Corey R. Arnold, Yannick Galipeau, Martin Pelchat, Stephanie Goguen, Elinor Simons, Theo J. Moraes, Piush J. Mandhane, Stuart E. Turvey, Shelly Bolotin, David M. Patrick, Jared Bullard, Lisa M. Lix, Natasha Doucas, Natalie Rodriguez, Fiona S.L. Brinkman, Padmaja Subbarao, Marc-André Langlois, Meghan B. Azad
medRxiv 2023.09.06.23294696; doi: https://doi.org/10.1101/2023.09.06.23294696
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
Rilwan Azeez, Larisa Lotoski, Geoffrey L. Winsor, Corey R. Arnold, Yannick Galipeau, Martin Pelchat, Stephanie Goguen, Elinor Simons, Theo J. Moraes, Piush J. Mandhane, Stuart E. Turvey, Shelly Bolotin, David M. Patrick, Jared Bullard, Lisa M. Lix, Natasha Doucas, Natalie Rodriguez, Fiona S.L. Brinkman, Padmaja Subbarao, Marc-André Langlois, Meghan B. Azad
medRxiv 2023.09.06.23294696; doi: https://doi.org/10.1101/2023.09.06.23294696

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)